MA-VERACODE
30.7.2024 14:53:34 CEST | Business Wire | Press release
Veracode, a global leader in application risk management, today announced the launch of its enhanced Veracode® Velocity™ Partner Program. The program enables new collaboration opportunities, empowering partners with innovative and comprehensive application and cloud risk management solutions across North America, LATAM, EMEA, and APAC. The expanded program introduces a simplified approach to working with resellers and value-added distributors.
Chris Peterson, Vice President of Global Channels at Veracode, emphasized the importance of the new program, saying, "The software security industry is experiencing a massive shift, with the explosion of AI accelerating global efforts to secure software. This is changing the way many partners do business as they require even more advanced industry-wide technical capabilities. With the launch of our enhanced global partner program, we are setting a new standard for collaboration in the software security industry.”
Through the Velocity™ program, partners can more easily support their customers to build and scale secure software from code to cloud with the Veracode application risk management platform. Partners can significantly enhance their security service offerings with AI-powered remediation, actionable visibility of exploitable flaws, and easy onboarding and integration with their DevSecOps tech stack. The company’s recent acquisition of Longbow Security also broadens Veracode’s market reach through its ecosystem of strategic security providers.
The Veracode® Velocity™ Partner Program has a multitiered structure tailored to various levels of engagement and investment. Benefits include early access to Veracode products, invitations to Veracode Technical Summits and Partner Technical Advisory Council membership, participation in thought leadership programs, revenue acceleration programs, and marketing investment.
As part of the Velocity™ program, Veracode has also unveiled its enhanced Partner Technical Certification Program. This initiative provides partners with technical certification across four progressive levels, retires any requirement for Continuing Professional Education, and builds visibility of expertise with Credly badges. These new certifications will help drive partners’ services and sales.
Game-Changing Impact
Veracode's new partner program is now active, with several partners already experiencing the benefits of enhanced collaboration and support.
Traci Byrne, Head of Global Security Strategy & GTM at World Wide Technology said, "Veracode's new partner program transforms the way we engage with security solutions. The structured tiers and clear incentives allow us to align our investments directly with outcomes, benefiting both our clients and our business strategy. This program not only supports our growth but also enhances our ability to deliver comprehensive security solutions to customers more effectively."
"Our team is very excited about the enhancements to Veracode's Partner Program,” said Michelle Jones, Senior Manager of Strategic Alliances at GuidePoint Security. “The clarity and simplicity of the program allows us to focus more on delivering value and less on navigating complexities. Through our strategic partnership, we can better serve our customers and drive significant advancements in application risk management."
Clint Huffaker, Application & API Security Practice Manager at World Wide Technology, said, “The Consultant Certification initiative from Veracode is a transformative step forward for partners, providing them with a structured pathway to enhance their technical skills. It is well designed to empower partners, boosting their ability to deliver superior services and drive business.”
Peterson closed, “The enhanced program directly addresses the growing needs of our partners, providing them with a clear path to success. Our goal is always to empower partners to grow their businesses while jointly delivering superior security solutions to our customers worldwide."
For more information about Veracode and the new partner program, please visit Veracode’s website.
About Veracode
Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, and Penetration Testing.
Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.
Copyright © 2024 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240730015405/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom